Company intelligence / Profile preview

Abacus Medicine

Copenhagen, Denmarkabacusmedicine.com ↗
Ownership
Private
Employees
~1200
Development stage
Commercial
01

Overview

Abacus Medicine is a market leader in parallel import of medicines in Europe, supplying more than 28,000,000 packs of prescription medicine each year

Therapeutic areas
OncologyMetabolic DisordersImmunologyRare DiseasesHematologyNeurology
Industry
Non-Academic Healthcare
02

Drug pipeline

1 asset

maralixibat

Commercial
Indications
Alagille syndrome, Progressive familial intrahepatic cholestasis

Beyond the preview

Go deeper on Abacus Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abacus Medicine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call